ABSTRACT
There is a growing awareness in natural plant products as the basis of novel pharmaceuticals and other biologically active compounds. The majority of screening for biological activities of herbal extracts has been done in the hunt for novel anti-cancer, anti-viral and anti-fertility drugs. The advancement of the fast screening trials nowadays used in manufacturing has intended that many other plants can be assessed for an extensive variety of biological activities. There still remains a crucial necessity to develop novel medical medications, and this can be illustrated by the several ailments such as cancer, hypertension, obesity, diabetes and other age-related disorders. Natural goods already have an established track record for various activities, and it is likely that there are more such remedies still to be found from the environment. Regrettably, the outcomes of such trials do not inevitably spread the public domain and are kept in inaccessible business records. This is a timely review of the latest advances and trends in a field which is becoming a commercially significant area of investigation for the pharmaceutical industry.
